Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-13

FDA Approved: GEMMILY — Supplemental Application (Xiromed, LLC)

View source ↗

Summary

FDA approved a supplemental application for GEMMILY, a combination oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GEMMILY (Norethindrone acetate and ethinyl estradiol, and ferrous fumarate)

Snippet

SUPPL AP for GEMMILY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)